Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications; Inno ...

Our mission is to support the development of Clinical Psychology, both as a profession and as a body of knowledge and skills. By working collaboratively with a number of organisations including the ...

Stanford Center for Biomedical Ethics (SCBE) has received a grant for expanding the Center for Ethical, Legal and Social Implications (ELSI) and Center for Resources and Analysis (CERA).

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

The company expects to submit a biologics license application for NTLA-2002 in 2026 and potentially launch it in the US in 2027.